perfluorooctanoic acid has been researched along with Hypertrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Butenhoff, JL; Chang, SC; Elcombe, BM; Elcombe, CR; Farrar, DG; Foster, JR; Jung, R; Kennedy, GL | 1 |
DePierre, JW; Eriksson, AM; Nelson, BD; Xie, Y; Yang, Q | 1 |
2 other study(ies) available for perfluorooctanoic acid and Hypertrophy
Article | Year |
---|---|
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARĪ± and CAR/PXR.
Topics: Animals; Apoptosis; Body Weight; Caprylates; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; DNA; Environmental Pollutants; Fluorocarbons; Hepatocytes; Hepatomegaly; Hypertrophy; Liver; Male; Organ Size; Peroxisomes; PPAR alpha; Pregnane X Receptor; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid | 2010 |
Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
Topics: Animals; Atrophy; Body Weight; Caprylates; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Fluorocarbons; Hypertrophy; Liver; Male; Mice; Mice, Inbred C57BL; Models, Animal; Organ Size; Peroxisome Proliferators; Peroxisomes; Phenotype; Spleen; Substance Withdrawal Syndrome; Thymus Gland; Time Factors | 2001 |